U.S. Personal Products Stock News

In February 2026, Microchip Technology expanded its edge AI offering into full-stack MCU and MPU platforms, announced an US$800 million zero-coupon senior unsecured convertible note due 2030, and participated in multiple semiconductor conferences, including the Chiplet Summit 2026 and Wolfe Research’s Auto, Auto Tech and Semiconductor Conference. The push into turnkey edge AI solutions, combining silicon, software, tools and pre-trained models, signals Microchip’s intent to move closer to...

Baidu (NasdaqGS:BIDU) and Uber are partnering to launch the Apollo Go autonomous ride hailing service in Dubai. The project represents Baidu's first large scale overseas deployment of its autonomous driving technology. Dubai plans to expand autonomous transportation by 2030, and this service is intended to support that city wide goal. The Dubai operation will be Baidu's first Apollo Go hub outside of China. For you as an investor looking at NasdaqGS:BIDU, this move places Baidu's core...

Gartner (NYSE:IT) is under investigation by a law firm following its fourth quarter financial results. The inquiry focuses on potential securities fraud or unlawful practices linked to the company’s recent disclosures. Gartner’s 2026 outlook missed expectations, prompting fresh scrutiny of management and investor communications. The investigation and earnings update are viewed as material for current and prospective shareholders. Gartner is a research and advisory firm that sells market...

If you are wondering whether Dynex Capital's current share price offers good value, you are not alone, especially with income focused investors often watching mortgage REITs closely. The stock last closed at US$14.13, with returns of 0.6% over 7 days, a 3.4% decline over 30 days, 0.4% year to date, 17.4% over 1 year, 59.2% over 3 years and 35.7% over 5 years. This raises fair questions about how that performance lines up with the underlying value. Recent coverage around Dynex Capital has...

In recent days, ACADIA Pharmaceuticals drew fresh attention after Wall Street analysts reacted to updates on its neurology and rare‑disease pipeline, highlighting the company’s transition from a single‑product focus to a broader portfolio with additional development‑stage and deal‑driven assets. This shift toward a more diversified set of neurology and genetic disorder programs has become a key talking point among analysts assessing how ACADIA balances Nuplazid’s importance with new...

If you are looking at Cytokinetics and wondering whether the current share price actually reflects its underlying value, you are not alone. The stock most recently closed at US$67.94, with returns of 2.5% over 7 days, 7.1% over 30 days, 10.1% year to date and 41.1% over the past year, which naturally raises questions about what is already priced in and what is not. Recent attention around Cytokinetics has focused on its pipeline progress and regulatory milestones, which often influence how...

Wondering whether Trane Technologies at around US$467 a share lines up with its underlying value, or if expectations have already run ahead of the story. The stock has posted returns of 0.4% over the last 7 days, 20.9% over the last 30 days, 17.4% year to date, 36.0% over 1 year and 214.8% over 5 years, which naturally raises questions about how much future upside or downside is now priced in. Recent news flow around Trane has highlighted ongoing attention on building efficiency and climate...

In February 2026, Trex Company expanded its Performance-Engineered outdoor living portfolio with cooler-running SunCom comfortable decking, new Transcend Lineage 1"x4" boards, enhanced railing options, and composite fencing, while appointing industry veteran Irene Tasi to its Board and Audit and Compensation Committees. Alongside these product launches and governance changes, Trex’s recent industry awards and sustainability rankings highlight a brand pushing innovation even as competitive...

Mattel (MAT) has given investors a lot to digest in February, pairing a new US$1.5b share repurchase authorization with detailed 2026 product reveals and fresh earnings and sales guidance. See our latest analysis for Mattel. Despite the new product slate and the US$1.5b buyback authorization, Mattel’s recent share price return has been weak, with a 30 day share price return of 15.77% and a 1 year total shareholder return of 17.84%. This suggests momentum has been fading even as management...

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...

Rosen Law Firm announced that the U.S. District Court for the Southern District of New York has certified a class action and is reviewing a proposed US$740,000,000 settlement to resolve claims by DiDi Global ADS purchasers, with a hearing scheduled for June 16, 2026. If approved, this sizable settlement would cap a major legal overhang for DiDi Global, clarifying potential liabilities and closing a lengthy litigation chapter. Next, we will examine how this proposed US$740,000,000 class...

What Restaurant Brands International’s Recent Trading Tells You Restaurant Brands International (QSR) has drawn investor interest after a modest 0.3% gain in the latest session, adding to a 4.1% move over the past week and contrasting with a slight past 3 months pullback. See our latest analysis for Restaurant Brands International. At a share price of $68.82, Restaurant Brands International’s recent 7 day share price return of 4.05% sits against a quieter year to date move. However, a 1 year...

Medpace Holdings (MEDP) recently reported quarterly results that came in ahead of market expectations and issued 2026 guidance, but a softer book to bill ratio and a new securities law investigation have complicated the story. See our latest analysis for Medpace Holdings. The share price has been under pressure recently, with a 30 day share price return of 22.83% and a 90 day share price return of 26.63%. However, the 1 year total shareholder return of 33.38% and 3 year total shareholder...

Smithfield Foods (SFD) is back on investors’ radar after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and the past three months. See our latest analysis for Smithfield Foods. The latest share price of US$25.04 sits alongside a 30 day share price return of 10.07% and a 90 day share price return of 18.50%. The 1 year total shareholder return of 24.16% points to momentum that has been building rather than fading. If recent...

If you are wondering whether ASML Holding’s share price still makes sense after a strong run, or if expectations have gone too far, this article will walk you through what the current market price might be implying. With the stock last closing at US$1,469.59 and returns of 4.5% over 7 days, 5.8% over 30 days, 26.3% year to date and 100.8% over 1 year, many investors are asking what is already priced in. Recent coverage has focused on ASML’s central role in supplying advanced semiconductor...

In February 2026, Howmet Aerospace completed several fixed‑rate senior unsecured note offerings totaling about US$1.20 billion, with maturities ranging from 2028 to 2036, to help finance its approximately US$1.80 billion proposed acquisition of Consolidated Aerospace Manufacturing and supplement borrowings under its commercial paper program and existing cash. This combination of debt‑funded acquisition plans, ongoing share repurchases, and solid 2025 earnings puts Howmet’s balance sheet,...

Dollar General (NYSE:DG) has launched a new Dollar General Market format featuring an expanded grocery assortment. The remodel brings more fresh produce, meat, and everyday food essentials to communities with limited grocery options. The change reflects the company’s focus on community investment and access to food in underserved areas. For you as an investor, this move sits at the intersection of discount retail and everyday essentials, an area where consistent foot traffic can matter as...

Why Goodyear’s latest earnings matter for shareholders Goodyear Tire & Rubber (GT) just reported fourth quarter and full year 2025 results, with stronger quarterly profit but a full year net loss, giving investors mixed signals on the stock’s recent performance. See our latest analysis for Goodyear Tire & Rubber. The mixed earnings story is also showing up in the trading data, with the 90 day share price return of 9.83% pointing to improving momentum. In contrast, the 1 year total shareholder...

Verra Mobility (VRRM) drew fresh investor attention after securing a 10 year contract worth roughly US$160 million with Hawaii’s Department of Transportation to expand its automated red light and speed enforcement program statewide. See our latest analysis for Verra Mobility. The Hawaii contract follows another large win with New York City earlier in February. Together, these updates contrast with a softer share price picture, with a 30-day share price return of an 11.16% decline, a...

If you are wondering whether DocuSign's current share price reflects its true worth, you are not alone. This article will help you frame that question clearly. With the stock closing at US$44.48 and returns of a 0.8% decline over 7 days, a 22.6% decline over 30 days, a 31.4% decline year to date and a 47.0% decline over 1 year, many investors are reassessing what a fair price looks like for DocuSign. Recent coverage has focused on how DocuSign is repositioning itself within the broader...

Paychex Director Joseph Doody recently acquired additional shares of NasdaqGS:PAYX, signaling increased personal exposure to the company. The insider purchase comes as Paychex shares trade at $91.24 following a 16.0% decline year to date. This transaction adds a fresh data point for investors watching insider activity at Paychex. For investors tracking Paychex, the timing of this insider buying stands out against a weaker recent share performance. The stock is at $91.24, with a 7 day return...

Earlier in February 2026, Albemarle said it had idled the last operating train at its Kemerton lithium hydroxide plant in Western Australia, recorded US$245.60 million of long‑lived asset impairments for the December 2025 quarter, and reported a quarterly net loss despite higher sales. At the same time, Albemarle guided to 2026 net sales of US$5.70 billion to US$6.00 billion with flat volumes, while shifting Kemerton into care and maintenance but planning to meet lithium hydroxide demand...

Voya Financial (VOYA) has launched a new fixed income offering of senior, unsecured fixed rate notes, shortly after filing an omnibus shelf registration that covers debt, equity, preferred stock, depositary shares, warrants, and units. See our latest analysis for Voya Financial. Voya’s new notes come after a period where momentum has softened slightly in the short term, with a 30 day share price return of a 1.83% decline. The 1 year total shareholder return of 6.56% and 5 year total...

If you are wondering whether Regeneron Pharmaceuticals is still priced fairly after a strong multi year run, or if the market is missing something in plain sight, this article will help you weigh what you are really paying for. The stock most recently closed at US$779.67, with returns of 3.5% over 30 days and 74.2% over 5 years, so recent moves and longer term performance give mixed signals on how the market is pricing its potential and risks. Recent headlines around Regeneron have focused...